Gerstenberg, G.; Stinn, W.; Reininghaus, W.
Environmental tobacco smoke (ETS) from an electrically heated cigarette (the Accord smoking system: U.S. test market, 2 mg tar) and a conventional lit-end cigarette (Merit cigarette: German market, 7 mg tar) was investigated. The Accord cigarette is made of conventional tobacco filler rolled in tobacco mat and smoked in a battery-operated lighter, which heats the tobacco during puffing. Because the tobacco does not burn continuously, the Accord smoking system delivers essentially no sidestream smoke. ETS was generated by 3 smokers each smoking 2 cigarettes in a 22 m(3) unventilated room. Constituents that could be measured with sufficient sensitivity were chosen from a list of commonly used markers for ETS or from a list of approximately 50 potentially toxicologically relevant mainstream smoke constituents. Concentrations of constituents were lower for Accord cigarettes than for Merit cigarettes: background-corrected concentrations of total particulate matter by 93 to 96% (determined by the Toem method, UV absorption, or fluorescence), solanesol by 89%, acetaldehyde and isoprene by 96%, and nicotine by 98%. For the majority of constituents, there was no difference between ETS generated by the Accord smoking system and background. Concentrations of carbon monoxide and benzene were lower by > 94%, toluene by > 96%, 3-ethenyl pyridine by > 98%, and 6 polyaromatic hydrocarbons (including benzo(a)pyrene) by > 97 to > 99.5%. The electrically heated cigarette produced substantially less ETS than the conventional cigarette as shown for 15 constituents.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.